Business article - May 24, 2024
Delsitech announces major licensing agreement
DelSiTech has announced that the company has entered into a licensing agreement with an undisclosed global pharmaceutical company. According to the agreement, DelSiTech grants an exclusive global license to DelSiTech’s Silica Matrix based, controlled release technology for development and commercialization of an undisclosed long-acting injectable drug product. Under the terms of the agreement, the licensee […]
Biotech Business - May 21, 2024
Immunovia carries out a rights issue of units of SEK 70 million
The Board of Directors of Immunovia has resolved to carry out an issue of shares and warrants with preferential rights for the company’s existing shareholders of initially approximately SEK 70 million. The company has received subscription undertakings amounting to a total of approximately SEK 1.3 million, corresponding to approximately 2 percent of the Rights Issue. […]
Collaboration - May 17, 2024
Pilot initiative by NNF to maintain the best health databases in Denmark
The initiative will provide funding to maintain high-quality health databases in the country and to support research that uses this data to advance understanding of cardiometabolic diseases (CMD). The aim is to ensure that valuable data remains both secure and accessible for future research, strengthening the CMD research environment in Denmark, states Novo Nordisk Foundation […]
Biotech Business - May 15, 2024
ArgusEye secures EUR 2.8 million
The funding round was led by Voima Ventures, with co-leadership from existing investor Eir Ventures, bringing the total raised by the company to EUR 3.45 million EUR. This funding will bolster the ongoing development of ArgusEye’s sensor platform, Auga, aimed at accelerating the bioprocessing workflow from early upstream to late formulation stages. Lene Gerlach, Partner […]
Business article - May 14, 2024
Trill Impact Ventures co-leads series B financing round in May Health
Together with Bpifrance, Trill Impact Ventures has co-led a USD 25 million series B financing round in May Health, a French-American medical device company targeting Polycystic Ovary Syndrome (PCOS) related infertility. The round also saw participation from existing May Health investor Sofinnova Partners. Proceeds will advance the clinical development of May Health’s innovative device, as […]
Financing - May 10, 2024
KLIFO makes strategic investment to expand its Clinical Trial Supply capacity in Denmark
The double-digit million DKK investment is to set up a new storage and CTS production facility for the pharmaceutical and biotech industries. The expansion site is situated in the Greater Copenhagen area in Medicon Valley. “Through this strategic investment, we are fortifying KLIFO’s foothold in the Nordics while laying a robust foundation for the future,” […]
